Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Acetate Promotes a Differential Energy Metabolic Response in Human HCT 116 and COLO 205 Colon Cancer Cells Impacting Cancer Cell Growth and Invasiveness.
Rodríguez-Enríquez S, Robledo-Cadena DX, Gallardo-Pérez JC, Pacheco-Velázquez SC, Vázquez C, Saavedra E, Vargas-Navarro JL, Blanco-Carpintero BA, Marín-Hernández Á, Jasso-Chávez R, Encalada R, Ruiz-Godoy L, Aguilar-Ponce JL, Moreno-Sánchez R. Rodríguez-Enríquez S, et al. Among authors: aguilar ponce jl. Front Oncol. 2021 Aug 3;11:697408. doi: 10.3389/fonc.2021.697408. eCollection 2021. Front Oncol. 2021. PMID: 34414111 Free PMC article.
Oxidative phosphorylation as a target to arrest malignant neoplasias.
Rodríguez-Enríquez S, Gallardo-Pérez JC, Marín-Hernández A, Aguilar-Ponce JL, Mandujano-Tinoco EA, Meneses A, Moreno-Sánchez R. Rodríguez-Enríquez S, et al. Curr Med Chem. 2011;18(21):3156-67. doi: 10.2174/092986711796391561. Curr Med Chem. 2011. PMID: 21671858 Review.
Multi-biomarker pattern for tumor identification and prognosis.
Rodríguez-Enríquez S, Pacheco-Velázquez SC, Gallardo-Pérez JC, Marín-Hernández A, Aguilar-Ponce JL, Ruiz-García E, Ruizgodoy-Rivera LM, Meneses-García A, Moreno-Sánchez R. Rodríguez-Enríquez S, et al. J Cell Biochem. 2011 Oct;112(10):2703-15. doi: 10.1002/jcb.23224. J Cell Biochem. 2011. PMID: 21678471 Review.
Identification of a metabolic and canonical biomarker signature in Mexican HR+/HER2-, triple positive and triple-negative breast cancer patients.
Pacheco-Velázquez SC, Gallardo-Pérez JC, Aguilar-Ponce JL, Villarreal P, Ruiz-Godoy L, Pérez-Sánchez M, Marín-Hernández A, Ruiz-García E, Meneses-García A, Moreno-Sánchez R, Rodríguez-Enríquez S. Pacheco-Velázquez SC, et al. Int J Oncol. 2014 Dec;45(6):2549-59. doi: 10.3892/ijo.2014.2676. Epub 2014 Sep 25. Int J Oncol. 2014. PMID: 25270118
Heart myxoma develops oncogenic and metastatic phenotype.
Pacheco-Velázquez SC, Gallardo-Pérez JC, Díaz D, Adán-Ladrón de Guevara A, Robledo-Cadena DX, Saavedra E, Ruiz-Godoy L, Jimenez-Hernández LR, Vargas-Barrón J, Aguilar-Ponce JL, Rodríguez-Enríquez S. Pacheco-Velázquez SC, et al. Among authors: aguilar ponce jl. J Cancer Res Clin Oncol. 2019 May;145(5):1283-1295. doi: 10.1007/s00432-019-02897-0. Epub 2019 Mar 21. J Cancer Res Clin Oncol. 2019. PMID: 30900156
17-β Estradiol up-regulates energy metabolic pathways, cellular proliferation and tumor invasiveness in ER+ breast cancer spheroids.
Pacheco-Velázquez SC, Ortega-Mejía II, Vargas-Navarro JL, Padilla-Flores JA, Robledo-Cadena DX, Tapia-Martínez G, Peñalosa-Castro I, Aguilar-Ponce JL, Granados-Rivas JC, Moreno-Sánchez R, Rodríguez-Enríquez S. Pacheco-Velázquez SC, et al. Among authors: aguilar ponce jl. Front Oncol. 2022 Nov 7;12:1018137. doi: 10.3389/fonc.2022.1018137. eCollection 2022. Front Oncol. 2022. PMID: 36419896 Free PMC article.
Alternating chemotherapy: gemcitabine and cisplatin with concurrent radiotherapy for treatment of advanced head and neck cancer.
Aguilar-Ponce JL, Granados-García M, Cruz López JC, Maldonado-Magos F, Alvarez-Avitia MA, Arrieta O, González-Ramírez I, Lara-Cruz G, Martinez-Juárez I, Medina-Santillan R, Castillo-Hernández C, De la Garza-Salazar J. Aguilar-Ponce JL, et al. Oral Oncol. 2013 Mar;49(3):249-54. doi: 10.1016/j.oraloncology.2012.09.008. Epub 2012 Oct 6. Oral Oncol. 2013. PMID: 23043985
Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck.
Aguilar-Ponce J, Granados-García M, Villavicencio V, Poitevin-Chacón A, Green D, Dueñas-González A, Herrera-Gómez A, Luna-Ortiz K, Alvarado A, Martínez-Said H, Castillo-Henkel C, Segura-Pacheco B, De la Garza J. Aguilar-Ponce J, et al. Ann Oncol. 2004 Feb;15(2):301-6. doi: 10.1093/annonc/mdh071. Ann Oncol. 2004. PMID: 14760126 Free article. Clinical Trial.
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors.
Candelaria M, Gallardo-Rincón D, Arce C, Cetina L, Aguilar-Ponce JL, Arrieta O, González-Fierro A, Chávez-Blanco A, de la Cruz-Hernández E, Camargo MF, Trejo-Becerril C, Pérez-Cárdenas E, Pérez-Plasencia C, Taja-Chayeb L, Wegman-Ostrosky T, Revilla-Vazquez A, Dueñas-González A. Candelaria M, et al. Ann Oncol. 2007 Sep;18(9):1529-38. doi: 10.1093/annonc/mdm204. Ann Oncol. 2007. PMID: 17761710 Free article. Clinical Trial.
33 results